Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
136
days
Association of the NOS1AP rs10494366 Genetic Variant With Drug‐Induced QT Prolongation
Authors
Christina A. Pippis; Ana I. Lopez‐Medina; Choudhary Anwar A. Chahal; Jasmine A. LuzumShow moreShow less
Affiliations
1. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor Michigan USA; 2. Center for Inherited Cardiovascular Diseases WellSpan Health Lancaster Pennsylvania USA; 3. Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA; 4. Department of Cardiology Barts Heart Centre London UKShow moreShow less
86
days
A Serverless Pharmacogenomic Risk Dashboard: Translating Ensemble Models and Model‐Based Scenario Rules to Clinical Decision Support
Authors
R. Jerome Dixon; Elvin T. PriceShow moreShow less
Affiliations
1. Department of Pharmacotherapy and Outcomes Science, School of Pharmacy Virginia Commonwealth University Richmond Virginia USA; 2. Ph.D. Program in Integrative Life Sciences, School of Life Sciences and Sustainability Virginia Commonwealth University Richmond Virginia USA; 3. ConvergenceLabs@VCU—Health Outcomes Virginia Commonwealth University Richmond Virginia USAShow moreShow less
208
days
Brexanolone, a First‐In‐Class Neurosteroid Medication: Mechanism of Action, Clinical, and Translational Science
Authors
Laura Gayanova; Katrina Sian; Jason Wells; Amber Fedin; YanFei QiShow moreShow less
Affiliations
1. Duquesne University Nasuti College of Osteopathic Medicine Pittsburgh Pennsylvania USAShow moreShow less
77
days
Empowering Clinical Development With Disease Progression Modeling: Recommendations From the Clinical Trials Transformation Initiative
Authors
Lindsay S. Kehoe; Shu Chin Ma; Jiang Liu; Qi Liu; Herbert Pang; Bruce Burnett; Reem Yunis; Karthik VenkatakrishnanShow moreShow less
Affiliations
1. The Clinical Trials Transformation Initiative Duke Clinical Research Institute Durham North Carolina USA; 2. Model‐Informed Drug Development and Quantitative Medicine Critical Path Institute Tucson Arizona USA; 3. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA; 4. PD Data Science & Analytics Genentech South San Francisco California USA; 5. Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda Maryland USA; 6. RAYS Partners Consulting Menlo Park California USA; 7. EMD Serono Research and Development Institute, Inc. Billerica Massachusetts USAShow moreShow less
131
days
Deep‐Learning: An Emerging Tool to Support Model‐Informed Drug Development
Authors
Roberto Gomeni; Françoise Bressolle‐GomeniShow moreShow less
Affiliations
1. R&D Department PharmacoMetrica La Fouillade FranceShow moreShow less
178
days
Device and Data Access Considerations for Digital Health Studies Using Consumer‐Grade Wearables: An Experience‐Based Tutorial
Authors
Mike Zhu; Joshua D. Spencer; Sherry Chesak; Magdalena Romanowicz; Mohit Chauhan; Liselotte N. Dyrbye; Paul E. Croarkin; William V. Bobo; Arjun P. AthreyaShow moreShow less
Affiliations
1. Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic Rochester Minnesota USA; 2. Digital Technology Organization, Information Technology Mayo Clinic Rochester Minnesota USA; 3. Department of Nursing Mayo Clinic Rochester Minnesota USA; 4. School of Nursing University of Minnesota Minneapolis Minnesota USA; 5. Department of Psychiatry and Psychology Mayo Clinic Rochester Minnesota USA; 6. Department of Psychiatry and Psychology Mayo Clinic Jacksonville Florida USA; 7. Department of Medicine University of Colorado School of Medicine Denver Colorado USA; 8. Mayo Clinic Children's Mayo Clinic Rochester Minnesota USA; 9. Department of Behavioral Sciences and Social Medicine Florida State University Tallahassee Florida USA; 10. Center for Medicine and Public Health Policy and Practice Florida State University Tallahassee Florida USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days